Search results
Apr 17, 2023 · Carbonic anhydrase inhibitors are a medication used to manage and treat glaucoma, idiopathic intracranial hypertension, altitude sickness, congestive heart failure, and epilepsy, among other diseases. Carbonic anhydrase inhibitors are considered part of the diuretic class of medications. This article reviews the indications, action, and contraindications for carbonic anhydrase inhibitors as ...
Jul 22, 2021 · Results suggest the discrepancy between expected and observed weight loss with SGLT2 inhibitors cannot be explained by increases in appetite or changes in appetite-regulating hormones. Further studies are needed to investigate alternative metabolic compensatory mechanisms to optimize weight loss with SGLT2 inhibitor use.
Oct 25, 2019 · ACE inhibitors prevent the body from making the hormone Angiotensin II. Ordinarily, this hormone narrows the blood vessels, which causes an increase in blood pressure and forces the heart to work ...
Aug 1, 2020 · Lipase inhibitors have become an important means of clinical obesity treatment. In Table 1, we list that orlistat has been widely used in clinical practice as an inhibitor on pancreatic triacylglycerol lipase and gastric triacylglycerol lipase. Table 1. Orlistat targeting sites and related reports. Interaction sites.
Nov 18, 2003 · Injection of PYY3-36, the gut-derived Y2R agonist, directly into the ARC inhibits food intake. The appetite inhibitory effects of PYY3-36 are absent in the Y2 knockout mouse (Batterham et al., 2002). Therefore it appears that circulating PYY3-36 inhibits appetite by acting directly on the arcuate nucleus to inhibit orexigenic NPY neurones.
Of note, only two studies of cholinesterase inhibitors, both observational, evaluated weight loss as the primary outcome of interest. One study from France of 486 patients treated with cholinesterase inhibitors found that 21% of patients experienced a weight loss of >=4%, but there was no meaningful control group for comparison.
Jul 17, 2023 · Cholinesterase inhibitors function to decrease the breakdown of acetylcholine. They SEe use in the treatment of Alzheimer and dementia symptoms. This activity describes the indications, action, and contraindications for cholinesterase inhibitors in treating dementia disorders and other uses within other specialties. Moreover, this activity will highlight the mechanism of action, adverse event ...
